About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...
The New York Mets reportedly agreed to re-sign first baseman Pete Alonso to a two-year, $54 million deal on Wednesday, keeping a fan favorite in New York.